You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

20 September 2017

PrEP trial for adolescents: a promising step forward for HIV prevention

A US trial among 15 to 17 year-old men who have sex with men (MSM) suggests this group stands to benefit hugely should pre-exposure prophylaxis (PrEP) be approved – and supported – for this age group.